The company is investing EUR 170 million (US$201 million) to expand its vaccine manufacturing site in France for its newest influenza vaccine. / read more /
The Danish biotechnology company has been awarded a sole-source BARDA contract valued at more than $539 million for a freeze-dried smallpox vaccine. / read more /
advertisement
advertisement
PharmTech 2017 Employment Trends
The editors of Pharmaceutical Technology Europe invite you to participate in the annual employment survey for individuals involved in bio/pharmaceutical development, formulation, or manufacturing.
BARDA has entered a $12-million contract with biopharmaceutical firm Achaogen for the late-stage development of an antibiotic against resistant bacteria, and as a potential treatment for biowarfare agent. / read more /
Both regulatory bodies are working on enhancements to their respective adverse event reporting systems in efforts to increase transparency and safety monitoring of drugs. / read more /
Johnson & Johnson’s Janssen Sciences Ireland UC will invest more than EUR 300 million to expand manufacturing capacity for biologic medicines at its Ireland facility. / read more /
The company is considering options for a full or partial separation of its consumer healthcare business, either through a spin-off, sale, or other transaction. / read more /
GE Healthcare opened a 3D printing lab in Sweden that will speed the launch of products for bio/pharma manufacturing, such as a custom chromatography column. / read more /
Focusing on whether the product meets its defined quality attributes should help one make reasonable, documentable, and defendable risk-based decisions. / read more /
Date: 24-26 October 2017 Venue: Messe Frankfurt, Germany
CPhI Worldwide, together with co-located events ICSE, InnoPack, P-MEC and FDF, hosts more than 42,000 visiting pharma professionals over three days. 2,500+ exhibitors from 153 countries gather at the event to network and take advantage of more than 150 free industry seminars. The exhibition covers every sector of the pharmaceutical market under one roof. / Read more/
New technologies, including single-use systems, are leading the push for faster production and higher titers. At the same time, ensuring quality in raw materials and water systems, and controlling contamination are paramount. In this Biologics and Sterile Manufacturing eBook, the editors explore key technology, process, and operational topics.
